The first-in-human study of the hydrogen sulfate (Hyd-sulfate) capsule of the MEK1/2 inhibitor AZD6244 (ARRY-142886): a phase I open-label multicenter trial in patients with advanced cancer.

U. Banerji; D.R. Camidge; H.M.W. Verheul; R. Agarwal; D. Sarker; S.B. Kaye; I.M. Desar; J.N. Timmer-Bonte; S.G. Eckhardt; K.D. Lewis; K.H. Brown; M.V. Cantarini; C. Morris; S.M. George; P.D. Smith; C.M. van Herpen

The first-in-human study of the hydrogen sulfate (Hyd-sulfate) capsule of the MEK1/2 inhibitor AZD6244 (ARRY-142886): a phase I open-label multicenter trial in patients with advanced cancer.

Translated title of the contribution: The first-in-human study of the hydrogen sulfate (Hyd-sulfate) capsule of the MEK1/2 inhibitor AZD6244 (ARRY-142886): a phase I open-label multicenter trial in patients with advanced cancer.

U. Banerji
, D.R. Camidge
, H.M.W. Verheul
, R. Agarwal
, D. Sarker
, S.B. Kaye
, I.M. Desar
, J.N. Timmer-Bonte
, S.G. Eckhardt
, K.D. Lewis
, K.H. Brown
, M.V. Cantarini
, C. Morris
, S.M. George
, P.D. Smith
, C.M. van Herpen

Division Imaging & Oncology

Research output: Contribution to journal › Article › Academic › peer-review

Translated title of the contribution	The first-in-human study of the hydrogen sulfate (Hyd-sulfate) capsule of the MEK1/2 inhibitor AZD6244 (ARRY-142886): a phase I open-label multicenter trial in patients with advanced cancer.
Original language	Undefined/Unknown
Pages (from-to)	1613-1623
Number of pages	11
Journal	Clinical Cancer Research
Volume	16
Issue number	5
Publication status	Published - 2010

Cite this

Banerji, U., Camidge, D. R., Verheul, H. M. W., Agarwal, R., Sarker, D., Kaye, S. B., Desar, I. M., Timmer-Bonte, J. N., Eckhardt, S. G., Lewis, K. D., Brown, K. H., Cantarini, M. V., Morris, C., George, S. M., Smith, P. D., & van Herpen, C. M. (2010). The first-in-human study of the hydrogen sulfate (Hyd-sulfate) capsule of the MEK1/2 inhibitor AZD6244 (ARRY-142886): a phase I open-label multicenter trial in patients with advanced cancer. Clinical Cancer Research, 16(5), 1613-1623.

@article{78dd3fadd8694e00a5a5848dacce741a,

title = "The first-in-human study of the hydrogen sulfate (Hyd-sulfate) capsule of the MEK1/2 inhibitor AZD6244 (ARRY-142886): a phase I open-label multicenter trial in patients with advanced cancer.",

author = "U. Banerji and D.R. Camidge and H.M.W. Verheul and R. Agarwal and D. Sarker and S.B. Kaye and I.M. Desar and J.N. Timmer-Bonte and S.G. Eckhardt and K.D. Lewis and K.H. Brown and M.V. Cantarini and C. Morris and S.M. George and P.D. Smith and \{van Herpen\}, C.M.",

year = "2010",

language = "Undefined/Unknown",

volume = "16",

pages = "1613--1623",

journal = "Clinical Cancer Research",

issn = "1078-0432",

publisher = "American Association for Cancer Research Inc.",

number = "5",

}

Banerji, U, Camidge, DR, Verheul, HMW, Agarwal, R, Sarker, D, Kaye, SB, Desar, IM, Timmer-Bonte, JN, Eckhardt, SG, Lewis, KD, Brown, KH, Cantarini, MV, Morris, C, George, SM, Smith, PD & van Herpen, CM 2010, 'The first-in-human study of the hydrogen sulfate (Hyd-sulfate) capsule of the MEK1/2 inhibitor AZD6244 (ARRY-142886): a phase I open-label multicenter trial in patients with advanced cancer.', Clinical Cancer Research, vol. 16, no. 5, pp. 1613-1623.

The first-in-human study of the hydrogen sulfate (Hyd-sulfate) capsule of the MEK1/2 inhibitor AZD6244 (ARRY-142886): a phase I open-label multicenter trial in patients with advanced cancer. / Banerji, U.; Camidge, D.R.; Verheul, H.M.W. et al.
In: Clinical Cancer Research, Vol. 16, No. 5, 2010, p. 1613-1623.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - The first-in-human study of the hydrogen sulfate (Hyd-sulfate) capsule of the MEK1/2 inhibitor AZD6244 (ARRY-142886): a phase I open-label multicenter trial in patients with advanced cancer.

AU - Banerji, U.

AU - Camidge, D.R.

AU - Verheul, H.M.W.

AU - Agarwal, R.

AU - Sarker, D.

AU - Kaye, S.B.

AU - Desar, I.M.

AU - Timmer-Bonte, J.N.

AU - Eckhardt, S.G.

AU - Lewis, K.D.

AU - Brown, K.H.

AU - Cantarini, M.V.

AU - Morris, C.

AU - George, S.M.

AU - Smith, P.D.

AU - van Herpen, C.M.

PY - 2010

Y1 - 2010

M3 - Article

SN - 1078-0432

VL - 16

SP - 1613

EP - 1623

JO - Clinical Cancer Research

JF - Clinical Cancer Research

IS - 5

ER -